Brief: Panbela Therapeutics To Acquire Cancer Prevention Pharmaceuticals

Panbela Therapeutics

22/02/2022 13:30

Feb 22 (Reuters) - Panbela Therapeutics Inc  PBLA.O :
    * PANBELA THERAPEUTICS, INC. TO ACQUIRE CANCER PREVENTION
PHARMACEUTICALS, INC.
    * PANBELA THERAPEUTICS INC - ACQUIRED LEAD ASSET WILL BEGIN
A
FULLY-FUNDED REGISTRATION TRIAL ANTICIPATED TO START BY YEAR-END
    * PANBELA THERAPEUTICS INC - ON A PRO FORMA BASIS, HOLDERS
OF
PANBELA COMMON STOCK ARE EXPECTED TO OWN APPROXIMATELY 59% OF
POST-MERGER HOLDING COMPANY
    * PANBELA THERAPEUTICS - CPP STOCKHOLDERS WILL BE ELIGIBLE
TO
RECEIVE CONTINGENT PAYMENTS TOTALING MAXIMUM OF $60 MILLION FROM
MILESTONE AND ROYALTY PAYMENTS
    * PANBELA THERAPEUTICS - HOLDERS OF CPP'S OUTSTANDING
CAPITAL
STOCK IMMEDIATELY PRIOR TO DEAL WILL RECEIVE SHARES OF COMMON
STOCK OF PANBELA ON CLOSING

Source text for Eikon:  ID:nGNX2Chvpr 
Further company coverage:  PBLA.O 

 ((reuters.briefs@thomsonreuters.com;))